REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sopharm Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Department Stores | Administrative Management and General Management Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Research and Development in the Social Sciences and Humanities | Advertising, Public Relations, and Related Services | Marketing Research and Public Opinion Polling | All Other Professional, Scientific, and Technical Services
Full name: Sopharm Sp. z o.o. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Sopharm Sp. z o.o. is a company in Poland, with a head office in Jablonna. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The enterprise was incorporated on December 31, 2003. It currently has a total number of 1 - 5 (2010) employees.

Headquarters
Ul. Panska 9
Jablonna; Mazowieckie; Postal Code: 05-110

Contact Details: Purchase the Sopharm Sp. z o.o. report to view the information.

Website: http://www.sopharm.pl

Basic Information
Total Employees:
Purchase the Sopharm Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Sopharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Sopharm Sp. z o.o. report to view the information.
Incorporation Date:
December 31, 2003
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
62.5%
Purchase this report to view the information.
37.5%
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
No results were found for this company.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo